Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients

Yair Gazitt, Marei Sammar, Abraham J. Treves, Noga Manny, Dorit Gurfel, Aaron Polliack

Resultado de la investigación: Articlerevisión exhaustiva

4 Citas (Scopus)

Resumen

Monoclonal anti GP-70 antibodies (BI) were generated in mice and used for screening of various malignant and non-malignant cell lines. The reactivity of these monoclonal antibodies was compared with that obtained with the polyclonal anti GP-70 antibody described in earlier studies [1-3]. The results indicated complete similarity in reactivity of both of the antibodies used. Furthermore, the reactivity of BI antibodies with cell samples obtained from a variety of leukemia and lymphoma patients and with peripheral blood samples from healthy blood donors was also very similar to the pattern of specificity described in earlier reports for the polyclonal preparation. From these studies we conclude that the monoclonal antibodies can substitute the polyclonal anti GP-70 antibodies in the diagnosis and subtyping of B-type leukemias and lymphomas.

Idioma originalEnglish (US)
Páginas (desde-hasta)101-108
Número de páginas8
PublicaciónImmunology Letters
Volumen12
N.º2-3
DOI
EstadoPublished - mar. 1986
Publicado de forma externa

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Huella

Profundice en los temas de investigación de 'Generation of a monoclonal anti-GP70 antibody and characterization of its reactivity with various human cell lines and cells from leukemia-lymphoma patients'. En conjunto forman una huella única.

Citar esto